Skip to content

Interest Paid at other companies

ALN
Alnylam PharmaceuticalsALNY
$64.2M-6.9%
Opko Health logo
Opko HealthOPK
$9.6M-30.2%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$1.32M-20.1%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$17K-39.3%
Precigen logo
PrecigenPGEN
$2.56M
Celcuity logo
CelcuityCELC
$5.89M+147%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Tectonic Therapeutics’s 10-K, filed March 20, 2025, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's interest paid?
Tectonic Therapeutics (TECX) reported interest paid of $48K in Q4 2024.
How has Tectonic Therapeutics's interest paid changed year-over-year?
Tectonic Therapeutics's interest paid increased by 41.2% year-over-year, from $34K to $48K.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.